Fogh; Jens

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fogh; Jens.The latest application filed is for "purification of recombinant human galactocerebroside b-galactosidase (rhgalc)".

Company Profile

0.8.11

Fogh; Jens - Lynge DK
Fogh; Jens - Hillerod DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for production and purification of recombinant lysosomal alpha-mannosidase Grant 10,159,718 - Fogh , et al. Dec	2018-12-25
Animal model of Krabbe's disease Grant 9,986,722 - Fogh , et al. June 5, 2	2018-06-05
Production and purification of recombinant arylsulfatase A Grant 9,957,489 - Fogh , et al. May 1, 2	2018-05-01
PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC) App 20180112202 - Fogh; Jens ; et al.	2018-04-26
Process For Production And Purification Of Recombinant Lysosomal Alpha-mannosidase App 20180036387 - Fogh; Jens ; et al.	2018-02-08
Process For Production And Purification Of Recombinant Lysosomal Alpha-mannosidase App 20150306186 - Fogh; Jens ; et al.	2015-10-29
PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC) App 20150284698 - Fogh; Jens ; et al.	2015-10-08
Animal Model Of Krabbe's Disease App 20150196014 - Fogh; Jens ; et al.	2015-07-16
Process for production and purification of recombinant lysosomal alpha-mannosidase Grant 8,974,780 - Fogh , et al. March 10, 2	2015-03-10
Production And Purification Of Recombinant Arylsulftase App 20140072548 - Fogh; Jens ; et al.	2014-03-13
Production and purification of recombinant arylsulftase Grant 8,536,315 - Fogh , et al. September 17, 2	2013-09-17
Process For Production And Purification Of Recombinant Lysosomal Alpha-mannosidase App 20120308549 - Fogh; Jens ; et al.	2012-12-06
Production and Purification of Recombinant Arylsulftase App 20080003211 - Fogh; Jens ; et al.	2008-01-03
Process for purification of recombinant porphobilinogen deaminase Grant 7,148,048 - Fogh , et al. December 12, 2	2006-12-12
Therapeutic method for treating patients with acute intermittent porphyria (AIP) and other porphyric diseases App 20030223979 - Gellerfors, Par ; et al.	2003-12-04
Production of recombinant human lysosomal alpha-mannosidase App 20030199073 - Fogh, Jens ; et al.	2003-10-23
Process for purification of recombinant porphobilinogen deaminase (rhPBGD) App 20030180926 - Fogh, Jens ; et al.	2003-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.